1. Home
  2. DXLG vs PBYI Comparison

DXLG vs PBYI Comparison

Compare DXLG & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXLG
  • PBYI
  • Stock Information
  • Founded
  • DXLG 1976
  • PBYI 2010
  • Country
  • DXLG United States
  • PBYI United States
  • Employees
  • DXLG N/A
  • PBYI N/A
  • Industry
  • DXLG Clothing/Shoe/Accessory Stores
  • PBYI Biotechnology: Pharmaceutical Preparations
  • Sector
  • DXLG Consumer Discretionary
  • PBYI Health Care
  • Exchange
  • DXLG Nasdaq
  • PBYI Nasdaq
  • Market Cap
  • DXLG 156.7M
  • PBYI 153.2M
  • IPO Year
  • DXLG 1987
  • PBYI N/A
  • Fundamental
  • Price
  • DXLG $2.76
  • PBYI $2.97
  • Analyst Decision
  • DXLG Buy
  • PBYI Strong Buy
  • Analyst Count
  • DXLG 2
  • PBYI 1
  • Target Price
  • DXLG $3.00
  • PBYI $7.00
  • AVG Volume (30 Days)
  • DXLG 303.5K
  • PBYI 821.3K
  • Earning Date
  • DXLG 11-22-2024
  • PBYI 02-27-2025
  • Dividend Yield
  • DXLG N/A
  • PBYI N/A
  • EPS Growth
  • DXLG N/A
  • PBYI 492.79
  • EPS
  • DXLG 0.15
  • PBYI 0.47
  • Revenue
  • DXLG $484,954,000.00
  • PBYI $243,569,000.00
  • Revenue This Year
  • DXLG N/A
  • PBYI N/A
  • Revenue Next Year
  • DXLG $2.85
  • PBYI N/A
  • P/E Ratio
  • DXLG $18.42
  • PBYI $6.38
  • Revenue Growth
  • DXLG N/A
  • PBYI 6.30
  • 52 Week Low
  • DXLG $2.15
  • PBYI $2.23
  • 52 Week High
  • DXLG $4.51
  • PBYI $7.73
  • Technical
  • Relative Strength Index (RSI)
  • DXLG 57.04
  • PBYI 45.95
  • Support Level
  • DXLG $2.47
  • PBYI $2.92
  • Resistance Level
  • DXLG $2.70
  • PBYI $4.06
  • Average True Range (ATR)
  • DXLG 0.11
  • PBYI 0.27
  • MACD
  • DXLG 0.01
  • PBYI -0.03
  • Stochastic Oscillator
  • DXLG 70.73
  • PBYI 4.39

About DXLG Destination XL Group Inc.

Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: